DW
Therapeutic Areas
Gandeeva Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| GND-323 | Oncology | IND-Enabling |
| GND-02 | Oncology | IND-Enabling |
| GND-03 | Oncology | IND-Enabling |
| GND-04 | Oncology | IND-Enabling |
| iGlues™ Platform | Oncology | Discovery |
Leadership Team at Gandeeva Therapeutics
SS
Sriram Subramaniam
Founder & CEO
DK
David Karp
Chief Financial Officer
JC
Jason Crawford
Executive Vice President, Drug Discovery
TC
Tom Ceska
Senior Director, Structural Biology and Cryo‑EM Operations
RS
Robert Sikorski
Chief Medical Officer